Berenjeno, Inma M.
PiƱeiro, Roberto
Castillo, Sandra D.
Pearce, Wayne
McGranahan, Nicholas
Dewhurst, Sally M.
Meniel, Valerie
Birkbak, Nicolai J.
Lau, Evelyn
Sansregret, Laurent
Morelli, Daniele
Kanu, Nnennaya
Srinivas, Shankar
Graupera, Mariona
Parker, Victoria E. R.
Montgomery, Karen G.
Moniz, Larissa S.
Scudamore, Cheryl L.
Phillips, Wayne A. http://orcid.org/0000-0002-7961-638X
Semple, Robert K.
Clarke, Alan
Swanton, Charles
Vanhaesebroeck, Bart
Article History
Received: 20 April 2016
Accepted: 1 November 2017
First Online: 24 November 2017
Competing interests
: B.V. is a consultant to Karus Therapeutics (Oxford, UK). C.S. discloses consulting and/or speaker fees from: Novartis, Eli Lilly, Roche, Pfizer, Celgene, Boehringer Ingelheim and Servier, and Scientific Advisory Board/ Stock options from: APOGEN Biotechnologies, EPIC Biosciences GRAIL, Achilles Therapeutics (co-founder and stock options). The remaining authors declare no competing financial interests.